Editor's PickMarket News

Milestone Scientific begins sales of CompuFlo epidural instruments and disposables to University Hospital of Wurzburg

Milestone Scientific Inc (NYSEAMERICAN:MLSS) said it has begun selling its CompuFloEpidural Instrument and related disposables to the University Hospital of Würzburg (UHW) in Germany. “We appreciate the decision of the University of Wurzburg, in association with Dr Kranke and his team, to purchase our CompuFlo Epidural System. Dr Kranke is a premier anesthesiologist and key opinion leader in the area of safe delivery of anesthesia and analgesia. We believe this initial order by a leading European hospital and medical teaching institute is further validation that our technology provides a level of safety and efficiency not available for medical professionals using conventional syringes. We look forward to further expanding our global rollout strategy of the CompuFlo Epidural System and working closely with other hospitals across Europe and North America”, Milestone president Arjan Haverhals said in a statement. READ: Milestone Scientific adds four new North American distributors for its Wand Single Tooth Anesthesia System “Based on the high accidental dural punctures with the loss of resistance that Dawkins found1 and our own published results on the CompuFlo2, we are impressed with Milestone Scientific’s CompuFlo Epidural Instrument. Introduction of the CompuFlo is an important step towards enhancing the safety of epidural analgesia and anesthesia. Based on the latest literature, the incidence of accidental dural puncture is considered high by modern standards, which is attributable to the standard loss of resistance technique used today. CompuFlo provides an attractive alternative as it addresses ‘false-positives’ and subsequent suboptimal analgesia. CompuFlo also holds significant potential given its ability to reduce complication rates”, said Dr Peter Kranke, professor of anesthesia in the department of anesthesia and critical care at UHW. “This agreement illustrates the positive response for our CompuFlo Epidural Instrument. In addition to hiring more salespeople and expanding our sales funnel, advanced trials are already underway that we believe will convert to commercial orders. We are now aggressively accelerating our commercialization efforts in both domestic and global markets as we pursue our goal to become the new standard of care”, added Milestone interim chief executive Leonard Osser. Milestone Scientific is a biomedical technology research and development company that patents, designs and develops innovative diagnostic and therapeutic injection technologies and instruments for medical, dental, cosmetic and veterinary applications. The company’s computer-controlled systems are designed to make injections precise, efficient, and virtually painless. Contact the author at calum@proactiveinvestors.com Follow him on Twitter @Cal_Proac

Leave a Reply

Your email address will not be published. Required fields are marked *

Get the daily email that makes reading the news actually enjoyable.Stay informed and entertained, for free.Subscribe to our newsletter












Your information is secure and your privacy is protected. By opting in you agree to receive emails from us and our affiliates. Remember that you can opt-out any time, we hate spam too!